LEUPOLIEVA DEPOT 3.75 MG
Leuprolide Acetate Depot for Injection 3.75 mg
LEUPOLIEVA DEPOT 3.75 MG (Leuprolide Acetate Depot for Injection 3.75 mg) is a prescription hormonal medicine containing Leuprolide Acetate 3.75 mg in a long-acting depot formulation. Leuprolide belongs to the Gonadotropin-Releasing Hormone (GnRH) Agonist class and is used to suppress the production of sex hormones. When administered continuously, Leuprolide initially stimulates the pituitary gland and subsequently reduces the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This results in a significant reduction in testosterone production in males and estrogen production in females. LEUPOLIEVA DEPOT 3.75 MG may be used in the management of advanced prostate cancer, endometriosis, uterine fibroids, and other approved hormone-dependent conditions, depending on the patient's clinical condition and the prescribing information applicable to the product. The depot formulation is designed to provide sustained release of Leuprolide Acetate, helping maintain hormonal suppression over the prescribed treatment interval. The injection should be prepared and administered by a qualified healthcare professional. LEUPOLIEVA DEPOT 3.75 MG is commonly used for: Advanced Prostate Cancer Hormone-Dependent Prostate Cancer Endometriosis Uterine Fibroids Hormonal Suppression Therapy Androgen Deprivation Therapy Hormone-Dependent Conditions Patients receiving Leuprolide therapy require regular monitoring of treatment response and relevant clinical parameters.
View Details